SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-16-016877
Filing Date
2016-04-28
Accepted
2016-04-28 09:17:10
Documents
8
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A ceru-defa14a_20151231.htm DEFA14A 87186
2 GRAPHIC g0wazdhjaeq3000001.jpg GRAPHIC 1041
3 GRAPHIC g0wazdhjaeq3000006.jpg GRAPHIC 1037
4 GRAPHIC g0wazdhjaeq3000005.jpg GRAPHIC 1529
5 GRAPHIC g0wazdhjaeq3000002.jpg GRAPHIC 1529
6 GRAPHIC g0wazdhjaeq3000004.jpg GRAPHIC 1036
7 GRAPHIC g0wazdhjaeq3000007.jpg GRAPHIC 3683
8 GRAPHIC g0wazdhjaeq3000003.jpg GRAPHIC 1529
  Complete submission text file 0001564590-16-016877.txt   104997
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36395 | Film No.: 161597395
SIC: 2834 Pharmaceutical Preparations